Related Experiment Video

Updated: Aug 14, 2026

Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System
14:55

Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System

Published on: May 12, 2013

Pharmacokinetics of antisense analogues in the central nervous system

A Szklarczyk1, L Kaczmarek

  • 1Nencki Institute of Experimental Biology, Warsaw, Poland.

Neurochemistry International
|September 1, 1997
PubMed

Insights

Oligodeoxyribonucleotides (ODN) show varied distribution and stability in the central nervous system (CNS). Phosphorothioate ODN offer greater stability, but cellular uptake remains a challenge for gene expression blocking applications.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • Oligodeoxyribonucleotides (ODN) are being explored for gene expression modulation in the central nervous system (CNS).
  • Understanding their pharmacokinetic properties is crucial for developing effective CNS therapies.

Purpose of the Study:

  • To evaluate the tissue distribution, stability, retention, and cellular uptake of different ODN analogues in the CNS.
  • To inform the rational design of ODN-based gene expression blockers for neurological applications.

Main Methods:

  • Analysis of tissue distribution, stability, retention, and cellular uptake of phosphodiester, phosphorothioate, and end-capped ODN analogues.
  • In vivo studies involving ODN administration into the CNS.

Main Results:

  • ODN distribute readily within nervous tissue, with penetration influenced by anatomical factors.
  • Phosphodiester ODN show higher retention, while phosphorothioate ODN exhibit superior tissue stability.
  • Cellular uptake by nerve cells is generally poor, though phosphorothioates can be internalized in vivo.
  • ODN metabolism within nerve cells produces higher molecular weight unidentified molecules.

Conclusions:

  • ODN analogues possess distinct pharmacokinetic profiles in the CNS, impacting their therapeutic potential.
  • Phosphorothioate ODN are more stable but face challenges in cellular internalization for gene silencing.
  • Further research is needed to optimize ODN delivery and uptake for effective CNS gene therapy.

More Related Videos

Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System07:47

Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System

Published on: October 29, 2019

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice04:41

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

Published on: February 24, 2026

Related Concept Videos

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Indirect-Acting Cholinergic Agonists: Pharmacokinetics01:22

Indirect-Acting Cholinergic Agonists: Pharmacokinetics

Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...